Results from the Phase 2 FAST Study of Astellas’ Investigational Zolbetuximab
Daniel Catenacci, MD, director of the Gastrointestinal Oncology Program at the University of Chicago, discusses data from Astellas’ Phase 2 FAST study...
5240 articles
Daniel Catenacci, MD, director of the Gastrointestinal Oncology Program at the University of Chicago, discusses data from Astellas’ Phase 2 FAST study...
William Flood, Chief Medical Officer for Eviti at Nanthealth discusses the newly launched Eviti Connect for autoimmune diseases. Used by over 6,900 on...
Heart disease is the leading cause of death for women in the United States, yet only about half of women recognize that heart disease is their number on...
Christoph Dankert discusses Carrum Health, the first digital health company directly connecting self-insured employers with the best providers in the na...
Jenice Baker, Assistant Medical Director of the Emergency Department and Attending Physician at Our Lady of Lourdes Hospital in Camden NJ, discusses the...
Heart failure (HF) accounts for nearly 2 hospitalizations every minute in the U.S. Beth Davidson, a HF nurse practitioner in Nashville, TN, and Presid...
Alicia Morgans, board-certified medical oncology physician at the Robert H. Learn more on Health Professional Radio.
Hospice patients with dementia are up to four times more likely to be disenrolled before death than patients without dementia (PWD).
Jonathan Edelman, MD, Vice President, Clinical Development at Seqirus discusses the Phase 3 clinical data presented at the 2021 Pediatric Academic Socie...
Oren Shuster, CEO of IM Cannabis, which offers government licensed cannabis products from generic to GMP-certified and pharmaceutical-grade, for both wh...